CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise | +69,051 | $1.74 | $120K | 69,051 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | −69,051 | $7.23 | $499K | 0 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise | +300,000 | $1.94 | $582K | 300,000 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale | −300,000 | $7.23 | $2.2M | 0 |
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) | −69,051 | 229,884 | ||
| 2025-11-20 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) | −300,000 | 200,000 | ||
| 2025-11-19 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Option exercise | +200,000 | $1.87 | $374K | 224,000 |
| 2025-11-19 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Sale | −200,000 | $7.14 | $1.4M | 24,000 |
| 2025-11-19 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Option exercise · Stock Option (Right to Buy) | −200,000 | 300,000 | ||
| 2025-11-19 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +15,000 | $1.87 | $28K | 30,000 |
| 2025-11-19 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −15,000 | $5.10 | $77K | 18,000 |
| 2025-11-19 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −15,000 | 470,000 | ||
| 2025-11-17 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +15,000 | $1.87 | $28K | 30,000 |
| 2025-11-17 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −15,000 | $4.77 | $71K | 15,000 |
| 2025-11-17 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −15,000 | 485,000 | ||
| 2025-10-27 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +100,000 | $1.74 | $174K | 100,000 |
| 2025-10-27 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −100,000 | $5.02 | $502K | 0 |
| 2025-10-27 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 298,935 | ||
| 2025-08-11 | Mashal Robert Director | Gift · Stock Option (Right to Buy) | −350,001 | 391,178 | ||
| 2025-08-11 | Mashal Robert Director | Gift · Stock Option (Right to buy) | +350,001 | 350,001 |
Page 4 of 15 · 291 trades